Edesa Biotech Inc - Company Profile
Powered by 
All the sales intelligence you need on Edesa Biotech Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Edesa Biotech Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Edesa Biotech Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Edesa Biotech Inc (Edesa) is a clinical-stage biopharmaceutical company focused on developing treatments for inflammatory and immune-related diseases. The company's pipeline products include EB05 which treats acute respiratory distress syndrome; EB01 for allergic contact dermatitis; EB06 which targets vitiligo. Edesa's products are intended for use in medical and healthcare applications, addressing unmet medical needs in these areas. The company operates primarily in the biopharmaceutical sector, with its clinical trials and research activities conducted in collaboration with various partners. Edesa Biotech is headquartered in Markham, Ontario, Canada.
Headquarters
Canada
Address
100 Spy Crt, Markham, Ontario, L3R5H6
Website
www.edesabiotech.com
Telephone
1 289 8009600
No of Employees
17
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
EDSA (NASD)
EPS
XYZ
Net Income (2024)
XYZ
-16.5%
(2024 vs 2023)
Market Cap*
$48.7M
Net Profit Margin (0 vs)
XYZ
0.0%
(2024 vs 2023)
* As of and is in US$
Edesa Biotech Inc premium industry data and analytics
Products and Services
| Products |
|---|
| Pipeline |
| EB01 - Allergic Contact Dermatitis |
| EB06 - Vitiligo |
Competitor Comparison
| Key Parameters | Edesa Biotech Inc | AbbVie Inc | Fortress Biotech Inc | Axim Biotechnologies Inc | biosyn Corp |
|---|---|---|---|---|---|
| Headquarters | Canada | United States of America | United States of America | United States of America | United States of America |
| City | Markham | North Chicago | Bay Harbor Islands | San Diego | Carlsbad |
| State/Province | Ontario | Illinois | Florida | California | California |
| No. of Employees | 17 | 57,000 | 78 | 6 | - |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Carlo Sistilli | Chairman | Executive Board | 2019 | 69 |
| Pardeep Nijhawan, MD | Director; Chief Executive Officer | Executive Board | 2019 | 55 |
| Peter J. Weiler | Chief Financial Officer | Senior Management | 2025 | 56 |
| Michael Brooks, PhD | President | Senior Management | 2019 | 47 |
| Gary Koppenjan | Vice President - Corporate Affairs | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer